Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Perinatal Infections Market to reach USD XX billion by the end of 2030.

Global Perinatal Infections Market Size Study & Forecast, by Infection Type (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others), By Diagnosis (Maternal Test, Neonatal Test, Others), By Treatment (Antibiotics, Antiviral, Antiretroviral, Others), By Route of Administration (Oral, Parenteral, Others), By End-user (Hospitals, Homecare, Specialty Clinics), and Regional Analysis, 2023-2030

Product Code: HLSMD-63931823
Publish Date: 27-06-2023
Page: 200

Global Perinatal Infections Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Perinatal infections are infections that occur during pregnancy or shortly after delivery, which can be transmitted from the mother to the fetus or newborn. These infections is generally caused by bacteria, viruses, fungi, or parasites that exhibit a serious impact on both the mother and the infant. Several common perinatal infections include cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, others. The surging cases of perinatal infections, growing awareness regarding treatment availability, rising number of government initiatives, spurring demand for personalized medicine, rising inclination towards point-of-care testing are the most prominent factors that are propelling the market demand across the globe.

In addition, the rising incidences of Human Immunodeficiency Virus (HIV) are exhibiting a positive influence on market growth across the globe. Pregnant women with HIV require antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission of the virus. Without proper treatment, the risk of transmission is high and leads to perinatal HIV infection, which can have serious health consequences for the newborn. According to HIV.gov, in 2021it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thereby, the growing awareness and initiatives for HIV prevention and treatment, along with the availability of ART is aids in lessening the chances of perinatal HIV infection, which, in turn, accelerates the global market growth. Moreover, the growing demand for retail pharmacies, as well as the increasing technological advancements in diagnostic tests presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and high cost involved in treatment are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Perinatal Infections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.

Major market players included in this report are:
Merck KGaA (Germany)
Beckman Coulter Inc. (U.S.)
BIOMERIEUX (France)
Bio-Rad Laboratories, Inc (U.S.)
Danaher (U.S.)
Hologic Inc. (U.S.)
Gilead Sciences, Inc. (U.S.)
Emcure Pharmaceuticals Limited. (India)
Cipla Inc. (U.S.)
Johnson & Johnson Private Limited (U.S.)

Recent Developments in the Market:
Ø In October 2021, Gilead Sciences, Inc. unveiled that the Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) has received U.S. Food and Drug Administration (FDA) approval for a new low-dose tablet dosage form for children and adolescents that are virologically suppressed or new to antiretroviral therapy and weigh between 14 kg and 25 kg. By approving this supplemental New Drug Application (sNDA), Biktarvy’s indication has been extended to encompass younger children who are HIV-infected, bridging the gap between paediatric and adult HIV treatment alternatives.

Global Perinatal Infections Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Infection Type, Diagnosis, Treatment, Route of Administration, End-user, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Infection Type:
Cytomegalovirus Infection
Enterovirus Infection
Genital Herpes
Gonorrhoea
Human Immunodeficiency Virus
Others

By Diagnosis:
Maternal Test
Neonatal Test
Others

By Treatment:
Antibiotics
Antiviral
Antiretroviral
Others

By Route of Administration:
Oral
Parenteral
Others

By End-user:
Hospitals
Homecare
Specialty Clinics

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Perinatal Infections Market, by Region, 2020-2030 (USD Billion)
1.2.2. Perinatal Infections Market, by Infection Type, 2020-2030 (USD Billion)
1.2.3. Perinatal Infections Market, by Diagnosis, 2020-2030 (USD Billion)
1.2.4. Perinatal Infections Market, by Treatment, 2020-2030 (USD Billion)
1.2.5. Perinatal Infections Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Perinatal Infections Market, by End-user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Perinatal Infections Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Perinatal Infections Market Dynamics
3.1. Perinatal Infections Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surging cases of perinatal infections
3.1.1.2. Rising incidences of Human Immunodeficiency Virus (HIV)
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.2.2. High cost involved in the treatment
3.1.3. Market Opportunities
3.1.3.1. Growing demand for retail pharmacies
3.1.3.2. Increasing technological advancements in diagnostic tests
Chapter 4. Global Perinatal Infections Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Perinatal Infections Market, by Infection Type
5.1. Market Snapshot
5.2. Global Perinatal Infections Market by Infection Type, Performance – Potential Analysis
5.3. Global Perinatal Infections Market Estimates & Forecasts by Infection Type 2020-2030 (USD Billion)
5.4. Perinatal Infections Market, Sub Segment Analysis
5.4.1. Cytomegalovirus Infection
5.4.2. Enterovirus Infection
5.4.3. Genital Herpes
5.4.4. Gonorrhoea
5.4.5. Human Immunodeficiency Virus
5.4.6. Others
Chapter 6. Global Perinatal Infections Market, by Diagnosis
6.1. Market Snapshot
6.2. Global Perinatal Infections Market by Diagnosis, Performance – Potential Analysis
6.3. Global Perinatal Infections Market Estimates & Forecasts by Diagnosis 2020-2030 (USD Billion)
6.4. Perinatal Infections Market, Sub Segment Analysis
6.4.1. Maternal Test
6.4.2. Neonatal Test
6.4.3. Others
Chapter 7. Global Perinatal Infections Market, by Treatment
7.1. Market Snapshot
7.2. Global Perinatal Infections Market by Treatment, Performance – Potential Analysis
7.3. Global Perinatal Infections Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
7.4. Perinatal Infections Market, Sub Segment Analysis
7.4.1. Antibiotics
7.4.2. Antiviral
7.4.3. Antiretroviral
7.4.4. Others
Chapter 8. Global Perinatal Infections Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Perinatal Infections Market by Route of Administration, Performance – Potential Analysis
8.3. Global Perinatal Infections Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Perinatal Infections Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Others
Chapter 9. Perinatal Infections Market, by End-user
9.1. Market Snapshot
9.2. Global Perinatal Infections Market by End-user, Performance – Potential Analysis
9.3. Global Perinatal Infections Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
9.4. Perinatal Infections Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Homecare
9.4.3. Specialty Clinics
Chapter 10. Global Perinatal Infections Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Perinatal Infections Market, Regional Market Snapshot
10.4. North America Perinatal Infections Market
10.4.1. U.S. Perinatal Infections Market
10.4.1.1. Infection Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Diagnosis breakdown estimates & forecasts, 2020-2030
10.4.1.3. Treatment breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030
10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Perinatal Infections Market
10.5. Europe Perinatal Infections Market Snapshot
10.5.1. U.K. Perinatal Infections Market
10.5.2. Germany Perinatal Infections Market
10.5.3. France Perinatal Infections Market
10.5.4. Spain Perinatal Infections Market
10.5.5. Italy Perinatal Infections Market
10.5.6. Rest of Europe Perinatal Infections Market
10.6. Asia-Pacific Perinatal Infections Market Snapshot
10.6.1. China Perinatal Infections Market
10.6.2. India Perinatal Infections Market
10.6.3. Japan Perinatal Infections Market
10.6.4. Australia Perinatal Infections Market
10.6.5. South Korea Perinatal Infections Market
10.6.6. Rest of Asia Pacific Perinatal Infections Market
10.7. Latin America Perinatal Infections Market Snapshot
10.7.1. Brazil Perinatal Infections Market
10.7.2. Mexico Perinatal Infections Market
10.8. Middle East & Africa Perinatal Infections Market
10.8.1. Saudi Arabia Perinatal Infections Market
10.8.2. South Africa Perinatal Infections Market
10.8.3. Rest of Middle East & Africa Perinatal Infections Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Merck KGaA (Germany)
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Beckman Coulter Inc. (U.S.)
11.3.3. BIOMERIEUX (France)
11.3.4. Bio-Rad Laboratories, Inc (U.S.)
11.3.5. Danaher (U.S.)
11.3.6. Hologic Inc. (U.S.)
11.3.7. Gilead Sciences, Inc. (U.S.)
11.3.8. Emcure Pharmaceuticals Limited. (India)
11.3.9. Cipla Inc. (U.S.)
11.3.10. Johnson & Johnson Private Limited (U.S.)
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now